Annelieke E.C.A.B. Willemsen

Nivolumab-associated Nephrotic Syndrome in a Patient With Renal Cell Carcinoma: A Case Report

Robin A. Daanen, Rutger Maas, Rutger H.T. Koornstra et al. · Journal of Immunotherapy · 2017 · 71 citations

Medicine, Nephrology, Pathology +17

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor

Heidi V.N. Küsters‐Vandevelde, Annelieke E.C.A.B. Willemsen, Patricia J.T.A. Groenen et al. · Acta Neuropathologica Communications · 2014 · 62 citations · Full text

Medicine, Dermatology, Oncology +17

A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients

Nielka P. van Erp, Carla M. van Herpen, Djoeke de Wit et al. · Clinical Pharmacokinetics · 2016 · 26 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer

Annelieke E.C.A.B. Willemsen, Lotte M. Knapen, Yvo M. de Beer et al. · European Journal of Clinical Pharmacology · 2017 · 25 citations · Full text

Pharmacy, Oncology, Pharmacology +13

Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations

Annelieke E.C.A.B. Willemsen, Sarah Krausz, Marjolijn J. L. Ligtenberg et al. · British Journal of Cancer · 2019 · 21 citations · Full text

Medicine, Molecular Medicine, Oncology +17